Tag: biosimilars

The Purple Book: Biosimilars and Interchangeability Explained

The FDA's Purple Book is the official guide to biosimilars and interchangeable biological products in the U.S. Learn how it helps pharmacists, doctors, and patients make informed choices about biological medicines.

Read more

Future Economic Trends: Forecasts for Generic Drug Markets

The global generic drug market is projected to grow to over $700 billion by 2030, driven by patent expirations, biosimilars, and cost pressures. Discover how India, China, and the U.S. are shaping the future of affordable medicine.

Read more